MYRIAD GENETICS, INC. Increase (Decrease) in Prepaid Expenses, Other
MYRIAD GENETICS, INC. (MYGN) reported Increase (Decrease) in Prepaid Expenses, Other of $6.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2026-07-31
- MYRIAD GENETICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-06-30 was -$2.80M.
- MYRIAD GENETICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2026-03-31 was $9.70M, a 340.91% increase year-over-year.
- MYRIAD GENETICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-12-31 was -$3.30M.
- MYRIAD GENETICS, INC. increase (decrease) in prepaid expenses, other for the quarter ending 2025-09-30 was $3.40M, a 36.00% increase year-over-year.
- MYRIAD GENETICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2025 was -$200.00K, a 105.41% decline from fiscal 2024.
- MYRIAD GENETICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2024 was $3.70M.
- MYRIAD GENETICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2023 was -$200.00K.
- MYRIAD GENETICS, INC. increase (decrease) in prepaid expenses, other for fiscal 2022 was -$1.60M, a 124.24% decline from fiscal 2021.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 6 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $6.90M 10-Q · filed 2026-07-31 | $3.60M derived: sum of 3 quarters · filed 2026-07-31 | $7.00M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2026-03-31 | $9.70M 10-Q · filed 2026-05-06 | $6.40M derived: sum of 2 quarters · filed 2026-05-06 | $9.80M derived: sum of 3 quarters · filed 2026-05-06 | $7.30M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-12-31 | -$3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $100.00K derived: sum of 2 quarters · filed 2026-02-24 | -$2.40M derived: sum of 3 quarters · filed 2026-07-31 | -$200.00K 10-K · filed 2026-02-24 | |
| 2025-09-30 | $3.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $900.00K derived: sum of 2 quarters · filed 2026-07-31 | $3.10M 10-Q · filed 2025-11-04 | $2.20M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-06-30 | -$2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | -$300.00K 10-Q · filed 2026-07-31 | -$1.20M derived: sum of 3 quarters · filed 2026-07-31 | $1.30M derived: sum of 4 quarters · filed 2026-07-31 | |
| 2025-03-31 | $2.20M 10-Q · filed 2026-05-06 | $1.30M derived: sum of 2 quarters · filed 2026-05-06 | $3.80M derived: sum of 3 quarters · filed 2026-05-06 | $700.00K derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.60M derived: sum of 2 quarters · filed 2026-02-24 | -$1.50M derived: sum of 3 quarters · filed 2026-02-24 | $3.70M 10-K · filed 2026-02-24 | |
| 2024-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$600.00K derived: sum of 2 quarters · filed 2025-11-04 | $4.60M 10-Q · filed 2025-11-04 | $2.60M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | -$3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.10M 10-Q · filed 2025-08-06 | $100.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.90M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $5.20M 10-Q · filed 2025-05-07 | $3.20M derived: sum of 2 quarters · filed 2026-02-24 | $5.00M derived: sum of 3 quarters · filed 2026-02-24 | $1.00M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$200.00K derived: sum of 2 quarters · filed 2026-02-24 | -$4.20M derived: sum of 3 quarters · filed 2026-02-24 | -$200.00K 10-K · filed 2026-02-24 | |
| 2023-09-30 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$2.20M derived: sum of 2 quarters · filed 2024-11-08 | $1.80M 10-Q · filed 2024-11-08 | $600.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | -$4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | -$1.20M derived: sum of 3 quarters · filed 2025-02-28 | $700.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $4.00M 10-Q · filed 2024-05-08 | $2.80M derived: sum of 2 quarters · filed 2025-02-28 | $4.70M derived: sum of 3 quarters · filed 2025-02-28 | -$600.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $700.00K derived: sum of 2 quarters · filed 2025-02-28 | -$4.60M derived: sum of 3 quarters · filed 2025-02-28 | -$1.60M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$3.40M derived: sum of 2 quarters · filed 2023-11-07 | -$400.00K 10-Q · filed 2023-11-07 | -$500.00K derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | -$5.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$2.30M 10-Q · filed 2023-08-04 | -$2.40M derived: sum of 3 quarters · filed 2024-02-28 | -$100.00K derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $3.00M 10-Q · filed 2023-05-04 | $2.90M derived: sum of 2 quarters · filed 2024-02-28 | $5.20M derived: sum of 3 quarters · filed 2024-02-28 | $7.10M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $2.20M derived: sum of 2 quarters · filed 2024-02-28 | $4.10M derived: sum of 3 quarters · filed 2024-02-28 | $6.60M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $4.20M derived: sum of 2 quarters · filed 2022-11-02 | $6.70M 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | $1.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $4.40M 10-Q · filed 2022-08-05 | $4.70M 10-Q · filed 2021-08-04 | ||
| 2021-03-31 | $2.50M 10-Q · filed 2022-05-06 | ||||
| 2020-12-31 | -$3.10M 10-K · filed 2023-03-01 | ||||
| 2020-09-30 | -$3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$5.40M 10-Q · filed 2021-11-04 | |||
| 2020-06-30 | -$2.40M 10-Q · filed 2021-08-04 | -$2.80M 10-K · filed 2023-03-01 | |||
| 2019-06-30 | $3.90M 10-K · filed 2022-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |